Revance Therapeutics, Inc. Financial Ratios — RVNC Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-218.4	-290.83	-58.5	-31.38	-37.18	-48.23	-54.62	-56.27	-53.2	-44.96	-64.04	-61.11
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	99.1	100	100	100	100	100	100	100	100	68.88	69.91	61.03	68.23
EBITDA Margin (%)	-4,623.88	-5,775.31	-5,890.44	-13,054.57	-23,440.67	-25,903.67	-44,285.88	-3,778.71	-39,116.22	-1,715.58	-327.54	-175.78	-89.15
Operating Margin (%)	-4,979.89	-6,023.15	-6,195.3	-13,590.08	-24,105.67	-26,385.33	-44,846.18	-3,824.99	-39,820.58	-1,782.46	-353.06	-205.31	-95
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-8,054.4	-8,125.38	-8,500.49	-16,427.42	-24,492	-29,756.67	-46,025.57	-3,742.77	-38,602.66	-1,857.81	-361.59	-268.34	-138.3
Profit Margin (%)	-8,054.4	-8,125.38	-8,500.49	-16,427.42	-24,492	-29,756.67	-46,025.57	-3,823.22	-38,602.66	-1,840.71	-361.59	-268.87	-138.43
Net Income to Common Margin (%)	-8,054.4	-8,125.38	-10,778.44	-16,427.42	-24,492	-29,756.67	-46,025.57	-3,823.22	-38,602.66	-1,840.71	-361.59	-268.87	-138.43
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	21.13	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Total Debt	69	106	25	4	8	5	2	- -	29	212	325	418	478
ST Debt	5	95	23	3	3	3	2	- -	3	4	5	5	11
LT Debt	64	11	3	1	5	2	- -	- -	26	208	320	414	468
Total Debt/EBITDA	-2.68	-2.57	-0.7	-0.07	-0.12	-0.07	-0.02	- -	-0.18	-0.81	-1.27	-1.8	-2.29
Net Debt/EBITDA	-1.45	-2.45	-0.59	3.37	2.87	0.82	2.44	0.52	1.06	0.58	-0.67	-1.16	-1.4
Total Debt/EBIT	-2.49	-2.46	-0.67	-0.07	-0.12	-0.07	-0.02	- -	-0.18	-0.78	-1.18	-1.54	-2.15
Net Debt/EBIT	-1.35	-2.35	-0.56	3.24	2.79	0.8	2.41	0.51	1.04	0.56	-0.62	-0.99	-1.31
EBITDA to Interest Expense	-1.45	-1.43	-2.4	-4.69	-59.09	-71.82	-253.89	-3,202.45	- -	-17.36	-40.62	-14.14	-10.78
EBITDA-CapEx/Interest Expense	-1.46	-1.44	-2.82	-5.34	-61.89	-75.03	-259.64	-10,361.8	- -	-17.63	-42.28	-14.34	-11.13
EBIT to Interest Expense	-1.56	-1.49	-2.52	-4.88	-60.77	-73.16	-257.11	-3,241.68	- -	-18.03	-43.79	-16.52	-11.49
Interest Expense	18	29	15	11	1	1	- -	- -	- -	15	6	16	19
Common Equity/Total Assets	-400.89	-1,626.51	-865	-134.45	-120.46	-206.26	-183.34	-302.52	-248.07	-156.37	-263.17	-301.48	-434.37
Long-Term Debt/Equity (%)	- -	- -	- -	0.34	2.11	1.06	- -	- -	11.47	55.48	467.01	3,282.19	- -
Long-Term Debt/Capital (%)	-70.75	-9.83	-1.54	-0.23	-1.65	-0.45	- -	- -	-3.17	-22.72	-29.79	-30.96	-29.23
Long-Term Debt/Total Assets (%)	161.38	81.95	11.62	0.31	1.94	0.92	- -	- -	7.6	28.83	60.2	71.07	97.73
Total Debt/Equity (%)	-44.37	-49.12	-16.18	2.01	3.35	3.02	0.7	- -	13.01	56.67	473.94	3,321.17	-315.58
Total Debt/Capital (%)	-75.74	-95.15	-14.96	-1.39	-2.62	-1.28	-0.35	- -	-3.6	-23.2	-30.23	-31.33	-29.91
Total Debt/Total Assets (%)	172.78	793.03	112.57	1.84	3.07	2.62	0.63	- -	8.62	29.45	61.09	71.91	100
Net Debt to Equity	-24.01	-46.8	-13.7	-95.48	-79.61	-35.86	-105.23	-50.31	-75.91	-40.89	248.3	2,146.1	-192.45
Net Debt/Capital (%)	-30.93	-87.46	-12.38	39.51	38.38	13.24	34.37	9.66	17.36	12.27	-14.36	-18.72	-16.8
EBITDA	-26	-41	-36	-50	-70	-78	-116	-141	-162	-263	-255	-233	-209
EBITDA-CapEx	-26	-42	-43	-57	-74	-81	-119	-456	-165	-267	-265	-236	-216
Operating Income (Loss)	-28	-43	-38	-52	-72	-79	-117	-143	-164	-273	-275	-272	-222

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Cash Ratio	3.35	0.03	0.08	16.71	20.96	9.44	13.53	5.5	7.08	7.16	3.34	4.5	2.85
Current Ratio	3.4	0.05	0.1	16.87	21.1	9.81	13.65	6.5	7.24	7.38	3.66	4.95	3.8
Quick Ratio	3.35	0.04	0.09	16.74	20.97	9.75	13.54	6.34	7.08	7.19	3.39	4.65	3.16
CFO/Avg Current Liab	- -	-0.61	-0.58	-1.91	-5	-3.78	-4.7	-3.94	-2.91	-3.5	-3.45	-2.71	-2.63
Common Equity/Total Assets	-400.89	-1,626.51	-865	-134.45	-120.46	-206.26	-183.34	-302.52	-248.07	-156.37	-263.17	-301.48	-434.37
Long-Term Debt/Equity (%)	- -	- -	- -	0.34	2.11	1.06	- -	- -	11.47	55.48	467.01	3,282.19	- -
Long-Term Debt/Capital (%)	-70.75	-9.83	-1.54	-0.23	-1.65	-0.45	- -	- -	-3.17	-22.72	-29.79	-30.96	-29.23
Long-Term Debt/Total Assets (%)	161.38	81.95	11.62	0.31	1.94	0.92	- -	- -	7.6	28.83	60.2	71.07	97.73
Total Debt/Equity (%)	-44.37	-49.12	-16.18	2.01	3.35	3.02	0.7	- -	13.01	56.67	473.94	3,321.17	-315.58
Total Debt/Capital (%)	-75.74	-95.15	-14.96	-1.39	-2.62	-1.28	-0.35	- -	-3.6	-23.2	-30.23	-31.33	-29.91
Total Debt/Total Assets (%)	172.78	793.03	112.57	1.84	3.07	2.62	0.63	- -	8.62	29.45	61.09	71.91	100
CFO/Total Liabilities	-14.54	-16.91	-26.5	-342.07	-246.65	-219.23	-355.04	-129.14	-92.48	-51.6	-47.88	-34	-34.37
CFO/CapEx	-189.42	-121.99	-7.37	-7.9	-16.73	-17.24	-36.32	-0.33	-32.87	-42.34	-21.35	-60.3	-31.45
Altman's Z-Score	-7.25	-43.39	-19.92	10.48	20.61	9.65	21.24	0.05	-0.48	-1.13	-6.39	-4.68	-5.93

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Accounts Receivable Turnover	- -	19.12	4.11	1.46	1.6	2.96	2.98	0.28	0.03	16.76	30.06	18.05	12
Days Sales Outstanding	- -	19.09	88.74	250.16	228.12	123.49	122.6	1,323.75	11,930.99	21.78	12.14	20.22	30.42
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.62	2.92	3.63	2.33
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	224.86	124.97	100.59	156.83
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.03	2.38	7.9	11.07
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	354.32	153.31	46.2	32.96
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	-107.68	-16.2	74.61	154.29
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	-203.08	-112.82	-80.38	-126.41
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	10	18	46
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	4
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	17
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10	13	24
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Market Capitalization	- -	- -	- -	328	831	582	1,076	728	705	1,644	1,102	1,342	744
- Cash & Cash Equivalents	30	4	4	171	202	64	283	73	171	334	111	109	137
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	69	106	25	4	8	5	2	- -	29	212	325	418	478
Enterprise Value	39	102	22	161	588	402	795	552	445	1,420	1,201	1,420	968
Total Capital	-91	-112	-170	-255	-324	-416	-540	-685	-815	-914	-1,073	-1,336	-1,600
Total Debt/Capital (%)	-75.74	-95.15	-14.96	-1.39	-2.62	-1.28	-0.35	- -	-3.6	-23.2	-30.23	-31.33	-29.91
Total Debt / EV	1.75	1.04	1.18	0.02	0.01	0.01	- -	- -	0.07	0.15	0.27	0.29	0.49
EV/Sales	70.68	142.77	34.97	420.37	1,958.83	1,339.32	3,034.7	148.12	1,076.5	92.63	15.44	10.71	4.14
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	2.62	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	328	831	582	1,076	728	705	1,644	1,102	1,342	744
Diluted Enterprise Value	39	102	22	161	638	524	795	655	564	1,523	1,316	1,652	1,085
EV per Share	5.49	14.26	1.22	8.3	24.14	14.29	26.41	15.27	10.23	24.47	17.79	19.53	11.44
TTM Sales	1	1	1	- -	- -	- -	- -	4	- -	15	78	133	234
TTM EBITDA	-26	-41	-36	-50	-70	-78	-116	-141	-162	-263	-255	-233	-209
TTM Operating Income	-28	-43	-38	-52	-72	-79	-117	-143	-164	-273	-275	-272	-222
TTM Cash Flow to Firm	-11	-10	-33	-44	-54	-59	-95	-104	-106	-163	-215	-177	-197
TTM Free Cash Flow to Firm	-10	-10	-26	-37	-51	-55	-92	211	-103	-159	-205	-174	-190

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023

Price/Free Cash Flow	- -	- -	- -	-6.83	-15.89	-10.33	-11.61	3.45	-6.85	-9.43	-5.22	-7.05	-3.55
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	39	102	22	161	588	402	795	552	445	1,420	1,201	1,420	968
Low Price	- -	- -	- -	14.02	14.1	12.35	18	17.16	9.88	11.78	12.34	11.27	5.72
EV/Sales	70.68	142.77	34.97	420.37	1,958.83	1,339.32	3,034.7	148.12	1,076.5	92.63	15.44	10.71	4.14
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-8	-8.99	-5.45	-5.98	-7.06	-3.92	-4.76	-6.09	-3.77	-5.84
Price/Earnings High	- -	- -	- -	-12.29	-14.05	-10.88	-9.29	-9.5	-5.68	-7.12	-8.12	-6.31	-9.92
Price/Earnings Low	- -	- -	- -	-4.32	-4.67	-3.89	-4.49	-4.35	-2.69	-2.42	-2.96	-2.3	-1.49
Price/Book Value	- -	- -	- -	-1.27	-2.5	-1.38	-1.98	-1.06	-0.84	-1.46	-0.79	-0.77	-0.36
Price/Book Value Average	- -	- -	- -	-1.94	-1.99	-1.15	-1.33	-1.47	-0.74	-1.19	-1.23	-0.77	-0.91
Price/Book Value High	- -	- -	- -	-2.99	-3.11	-2.3	-2.07	-1.98	-1.07	-1.78	-1.63	-1.28	-1.55
Price/Book Value Low	- -	- -	- -	-1.05	-1.03	-0.82	-1	-0.91	-0.51	-0.61	-0.6	-0.47	-0.23
Price/Tangible Book Value	- -	- -	- -	1.86	3.28	3.29	4	5	3.13	10.54	-8.23	-13.43	-4.61
Price/Tangible Book Value Average	- -	- -	- -	2.85	2.61	2.75	2.68	6.92	2.77	8.62	-12.81	-13.44	-11.72
Price/Tangible Book Value High	- -	- -	- -	4.38	4.08	5.49	4.17	9.3	4.01	12.87	-17.07	-22.52	-19.91
Price/Tangible Book Value Low	- -	- -	- -	1.54	1.36	1.96	2.02	4.26	1.9	4.38	-6.22	-8.2	-3
Price/Sales	- -	- -	- -	857.68	2,771.57	1,939.92	4,107.31	195.26	1,707.91	107.27	14.16	10.13	3.18
Price/Sales Average	- -	- -	- -	1,313.72	2,201.04	1,620.51	2,753.14	270.04	1,514.74	87.7	22.03	10.13	8.08
Price/Sales High	- -	- -	- -	2,018.14	3,440.93	3,237.89	4,273.9	363.27	2,191.98	131.05	29.36	16.98	13.73
Price/Sales Low	- -	- -	- -	709.84	1,144	1,157.39	2,068.02	166.45	1,039.69	44.59	10.71	6.18	2.07
Price/Cash Flow	- -	- -	- -	-5.96	-14.94	-9.73	-11.29	-6.98	-6.64	-9.21	-4.97	-6.94	-3.43
Price/Cash Flow Average	- -	- -	- -	-9.14	-11.86	-8.13	-7.57	-9.66	-5.89	-7.53	-7.74	-6.94	-8.74
Price/Cash Flow High	- -	- -	- -	-14.03	-18.54	-16.24	-11.74	-12.99	-8.53	-11.25	-10.31	-11.63	-14.84
Price/Cash Flow Low	- -	- -	- -	-4.94	-6.17	-5.8	-5.68	-5.95	-4.04	-3.83	-3.76	-4.23	-2.23
Price/Free Cash Flow Average	- -	- -	- -	-10.46	-12.62	-8.63	-7.78	4.78	-6.08	-7.71	-8.12	-7.05	-9.02
Price/Free Cash Flow High	- -	- -	- -	-16.07	-19.72	-17.24	-12.08	6.43	-8.8	-11.52	-10.82	-11.82	-15.32
Price/Free Cash Flow Low	- -	- -	- -	-5.65	-6.56	-6.16	-5.84	2.95	-4.17	-3.92	-3.95	-4.31	-2.31
EV/Sales Average	70.68	142.77	34.97	876.4	1,557.26	1,426.66	1,680.53	250.4	1,171.35	79.77	24.78	12.46	9.54
EV/Sales High	70.68	142.77	34.97	1,580.82	2,797.15	3,044.04	3,201.29	343.62	1,848.59	123.12	32.1	19.31	15.19
EV/Sales Low	70.68	142.77	34.97	272.53	500.22	963.54	995.41	146.81	696.3	36.67	13.46	8.52	3.53
EV/EBITDA Average	-1.53	-2.47	-0.59	-6.71	-6.64	-5.51	-3.79	-6.63	-2.99	-4.65	-7.57	-7.09	-10.7
EV/EBITDA High	-1.53	-2.47	-0.59	-12.11	-11.93	-11.75	-7.23	-9.09	-4.73	-7.18	-9.8	-10.99	-17.03
EV/EBITDA Low	-1.53	-2.47	-0.59	-2.09	-2.13	-3.72	-2.25	-3.89	-1.78	-2.14	-4.11	-4.84	-3.95
EV/EBIT Average	-1.42	-2.37	-0.56	-6.45	-6.46	-5.41	-3.75	-6.55	-2.94	-4.48	-7.02	-6.07	-10.04
EV/EBIT High	-1.42	-2.37	-0.56	-11.63	-11.6	-11.54	-7.14	-8.98	-4.64	-6.91	-9.09	-9.41	-15.99
EV/EBIT Low	-1.42	-2.37	-0.56	-2.01	-2.08	-3.65	-2.22	-3.84	-1.75	-2.06	-3.81	-4.15	-3.71
Last Price	- -	- -	- -	16.94	34.16	20.7	35.75	20.13	16.23	28.34	16.32	18.46	8.79
High Price	- -	- -	- -	39.86	42.41	34.55	37.2	37.45	20.83	34.62	33.83	30.95	37.98
Enterprise Value Average	39	102	22	336	467	428	440	934	484	1,223	1,928	1,652	2,233
Enterprise Value High	39	102	22	605	839	913	839	1,281	763	1,887	2,498	2,560	3,554
Enterprise Value Low	39	102	22	104	150	289	261	547	288	562	1,047	1,129	825

Shares Outstanding	18	18	18	24	28	29	37	37	52	69	72	82	88
Diluted Weighted Avg Shares	7	7	18	19	24	28	30	36	43	58	68	73	85
Basic Weighted Avg Shares	7	7	18	19	24	28	30	36	43	58	68	73	85
Revenue per Share	0.08	0.1	0.03	0.02	0.01	0.01	0.01	0.1	0.01	0.26	1.15	1.82	2.77
EBITDA per Share	-3.59	-5.77	-2.05	-2.58	-2.89	-2.76	-3.85	-3.9	-3.72	-4.53	-3.77	-3.2	-2.47
Operating Income per Share	-3.86	-6.02	-2.15	-2.68	-2.97	-2.82	-3.9	-3.94	-3.78	-4.71	-4.07	-3.74	-2.63
Basic EPS, GAAP	-6.25	-8.12	-3.75	-3.24	-3.02	-3.18	-4.01	-3.94	-3.67	-4.86	-4.17	-4.9	-3.83
Basic EPS from Cont Ops	-6.25	-8.12	-2.96	-3.24	-3.02	-3.18	-4.01	-3.94	-3.67	-4.86	-4.17	-4.9	-3.83
Diluted EPS, GAAP	-6.25	-8.12	-3.75	-3.24	-3.02	-3.18	-4.01	-3.94	-3.67	-4.86	-4.17	-4.9	-3.83
Diluted EPS from Cont Ops	-6.25	-8.12	-2.96	-3.24	-3.02	-3.18	-4.01	-3.94	-3.67	-4.86	-4.17	-4.9	-3.83
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-3.96	-5.42	-2.69	-2.84	-2.29	-2.13	-3.17	-2.88	-2.44	-3.08	-3.28	-2.66	-2.56
Free Cash Flow per Basic Share	-3.98	-5.47	-3.06	-3.2	-2.42	-2.25	-3.25	-11.59	-2.52	-3.15	-3.44	-2.71	-2.64
Cash & Equivalents per Share	4.13	0.57	0.22	8.82	10.37	6.6	9.4	4.86	6.68	7.52	3.33	4.69	3
Book Value per Share	-22.3	-30.42	-11.04	-13.34	-13.65	-14.99	-18.01	-18.93	-19.42	-19.41	-20.71	-24.13	-24.57
Tangible Book Value per Share	-21.66	-30.2	-8.88	9.1	10.4	6.3	8.93	4.03	5.19	2.69	-1.98	-1.37	-1.91

Revance Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)